Tasly (600535)
SSE · 600535
Market Cap$21.0B
Revenue$8.3B
Employees10563
Listed OnSSE
Ticker600535
CEO / ExecMr. Jin Yong Cai
HeadquartersTianjin
MarketMainland China
Websitewww.taslypharma.com
Overview
Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore activities. The comp
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.